300138 晨光生物
按盤價 
10.490 -0.020 (-0.190%)
10.490 -0.020 (-0.190%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.819 | 11.352 | 2.859 | 14.460 | 14.589 |
| 總資產報酬率 ROA (%) | 0.939 | 3.982 | 1.071 | 6.205 | 6.740 |
| 投入資產回報率 ROIC (%) | 0.995 | 4.256 | 1.144 | 6.632 | 7.178 | 邊際利潤分析 |
| 銷售毛利率 (%) | 13.681 | 13.101 | 7.962 | 11.612 | 13.941 |
| 營業利潤率 (%) | 6.977 | 6.653 | 1.516 | 7.980 | 7.735 |
| 息稅前利潤/營業總收入 (%) | 8.647 | 7.557 | 2.562 | 8.778 | 8.331 |
| 淨利潤/營業總收入 (%) | 6.041 | 5.715 | 1.115 | 7.192 | 6.927 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 94.236 | 86.858 | 117.956 | 75.690 | 91.139 |
| 價值變動淨收益/利潤總額(%) | -1.286 | 12.704 | 11.853 | 13.316 | 6.667 |
| 營業外收支淨額/利潤總額(%) | 0.195 | 0.345 | 0.851 | 1.348 | 2.939 | 償債能力分析 |
| 流動比率 (X) | 1.238 | 1.285 | 1.481 | 1.611 | 1.787 |
| 速動比率 (X) | 0.693 | 0.554 | 0.641 | 0.802 | 1.049 |
| 資產負債率 (%) | 68.234 | 63.817 | 65.035 | 58.637 | 53.579 |
| 帶息債務/全部投入資本 (%) | 64.879 | 59.329 | 60.696 | 54.312 | 48.148 |
| 股東權益/帶息債務 (%) | 50.757 | 64.141 | 60.772 | 79.749 | 101.822 |
| 股東權益/負債合計 (%) | 45.872 | 55.876 | 52.992 | 69.308 | 85.313 |
| 利息保障倍數 (X) | 5.221 | 8.573 | 2.480 | 12.737 | 23.063 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 26.702 | 25.857 | 23.489 | 20.087 | 19.923 |
| 存貨周轉天數 (天) | 262.755 | 255.520 | 197.437 | 155.053 | 141.589 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 22/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
